Abstract
The introduction of chemical inhibitors into living cells at specific times in development is a useful method for investigating the roles of specific proteins or cytoskeletal components in developmental processes. Some embryos, such as those of Caenorhabditis elegans, however, possess a tough eggshell that makes introducing drugs and other molecules into embryonic cells challenging. We have developed a procedure using carbon-reinforced nanopipettes (CRNPs) to deliver molecules into C. elegans embryos with high temporal control. The use of CRNPs allows for cellular manipulation to occur just subsequent to meiosis II with minimal damage to the embryo. We have used our technique to replicate classical experiments using latrunculin A to inhibit microfilaments and assess its effects on early polarity establishment. Our injections of latrunculin A confirm the necessity of microfilaments in establishing anterior-posterior polarity at this early stage, even when microtubules remain intact. Further, we find that latrunculin A treatment does not prevent association of PAR-2 or PAR-6 with the cell cortex. Our experiments demonstrate the application of carbon-reinforced nanopipettes to the study of one temporally-confined developmental event. The use of CRNPs to introduce molecules into the embryo should be applicable to investigations at later developmental stages as well as other cells with tough outer coverings.
Introduction
In developmental biology, timing is critical. Understanding the function of specific proteins often requires chemical inhibitors to "turn off" components at precise moments. However, the Caenorhabditis elegans embryo is protected by a formidable chitinous eggshell and a permeability barrier, shielding it from environmental factors and most pharmacological agents.
Existing methods to bypass this barrier have significant drawbacks. Genetic mutants and RNAi are often "always on" or take hours to manifest, precluding the study of rapid transitions. Physical methods like "popping" (pressure-permeabilization) or laser perforation often result in lethal damage or poor control over drug concentration due to reliance on passive diffusion. To address these challenges, we developed a "surgical" microinjection approach using carbon-reinforced nanopipettes (CRNPs) to deliver precise doses through the eggshell with minimal trauma.
Methods: Fabrication and Implementation of CRNPs
Standard glass or quartz micropipettes are typically too fragile for the scales required to pierce a C. elegans embryo; they often break upon impact or cause terminal leakage. The CRNP overcomes these limitations through a multi-step fabrication process.
Quartz capillaries are first coated internally with an iron catalyst and pulled to a fine point. Chemical Vapor Deposition (CVD) is then used to grow a thin layer of carbon inside the tip. This reinforcement results in tips with an outer diameter of approximately 135 ± 66 nm. The carbon lining provides the structural integrity necessary to pierce the tough eggshell while maintaining the flexibility to avoid snapping.
For the injection, a dual-micromanipulator setup is employed. A "holding pipette" provides light suction to stabilize the embryo while the CRNP pierces the opposite side. Calibration using fluorescent dyes in glycerol droplets indicates a mean injection volume of ~10 femtoliters (fL), representing roughly 0.1% of the total embryo volume.
Experimental Design
This study utilized various transgenic C. elegans strains expressing fluorescently tagged proteins to visualize cellular dynamics during injection:
- TY3558 & KK1177: For tracking histones (DNA), tubulin (microtubules), and myosin (contractility).
- KK1169: For tracking essential polarity proteins PAR-2 and PAR-6.
- N2 (Bristol): Standard wild-type strain for control experiments.
Results and Discussion
The CRNP technique demonstrated high efficacy and minimal biological impact. Control injections of DAPI dye showed 100% survival (6/6 embryos), with all specimens proceeding to hatch normally. The entire procedure, from piercing to withdrawal, is completed in approximately 30 seconds, providing exceptional temporal resolution.
Actin as the Primary Driver of Polarity
By injecting Latrunculin A (LatA) to depolymerize actin, we confirmed that the clearing of PAR proteins to establish the anterior-posterior axis is driven by actomyosin flows. Crucially, even when microtubules remained perfectly intact (verified via GFP-tubulin imaging), the loss of actin completely halted the establishment of cortical polarity. This suggests that microtubules are insufficient to drive polarity establishment in the absence of a functional actin cytoskeleton.
Dosage-Dependent Phenotypes
The ability to titrate the injected dose (e.g., 60 µM vs. 90 µM LatA) revealed nuances previously obscured by "all-or-nothing" methods. At moderate doses, PAR-2 proteins exhibited a confused localization pattern, appearing at both the cell cortex and the centrosomes. High-dose (90 µM) injections resulted in a total failure of PAR-2 cortical localization.
Conclusion and Future Directions
While highly effective, the technique faces some limitations. At the highest concentrations of LatA, chemical toxicity can lead to developmental arrest. Future work may involve functionalizing the nanopipettes with nanoparticles or liposomes for targeted release at specific intracellular coordinates.
Beyond C. elegans, CRNPs represent a platform technology applicable to any cell type protected by a tough outer layer, such as plant cells or other nematode species, offering a powerful tool for high-precision temporal and spatial manipulation in cell biology.
Summary updated